152 related articles for article (PubMed ID: 19825338)
21. [A 21-year-old male patient with nephrotic syndrome and "idiopathic" AA amyloidosis].
Saura IM; Carretón A; López Guillén E; Alegría MS; Jimeno García L; Ferri B
Nefrologia; 2004; 24 Suppl 3():109-12. PubMed ID: 15219083
[TBL] [Abstract][Full Text] [Related]
22. Amyloid A-type renal amyloidosis in a patient with sarcoidosis: report of a case and review of the literature.
Komatsuda A; Wakui H; Ohtani H; Maki N; Nimura T; Takatsu H; Yamaguchi A; Imai H; Sawada K
Clin Nephrol; 2003 Oct; 60(4):284-8. PubMed ID: 14579945
[TBL] [Abstract][Full Text] [Related]
23. AA amyloidosis: Mount Sinai experience, 1997-2012.
Bunker D; Gorevic P
Mt Sinai J Med; 2012; 79(6):749-56. PubMed ID: 23239212
[TBL] [Abstract][Full Text] [Related]
24. AA amyloidosis is an emerging cause of nephropathy in obese patients.
Stankovic Stojanovic K; Georgin-Lavialle S; Poitou C; Buob D; Amselem S; Grateau G;
Eur J Intern Med; 2017 Apr; 39():e18-e20. PubMed ID: 28214252
[No Abstract] [Full Text] [Related]
25. Amyloidosis: A cancer-derived paraproteinemia and kidney involvement.
Małyszko J; Kozłowska K; Małyszko JS
Adv Med Sci; 2017 Mar; 62(1):31-38. PubMed ID: 28153807
[TBL] [Abstract][Full Text] [Related]
26. Rheumatic heart disease associated with secondary renal amyloidosis.
Abdallah EA
Arab J Nephrol Transplant; 2012 Sep; 5(3):149-52. PubMed ID: 22967253
[TBL] [Abstract][Full Text] [Related]
27. Serum amyloid A renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user.
Cooper C; Bilbao JE; Said S; Alkhateeb H; Bizet J; Elfar A; Davalos O; Meza AT; Hernandez GT
J Nephropathol; 2013 Jul; 2(3):196-200. PubMed ID: 24475449
[TBL] [Abstract][Full Text] [Related]
28. [Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature].
Elloumi H; Ben Slama A; Arfaoui D; Ghouma M; Sfar S; Ajmi S
Tunis Med; 2006 Apr; 84(4):253-5. PubMed ID: 16832997
[TBL] [Abstract][Full Text] [Related]
29. [Renal amyloidosis secondary to hydatid cyst of the liver. Clinical remission after surgical excision].
Kaaroud H; Ben Moussa F; Béji S; Kheder A; Ben Maïz H
Nephrologie; 2002; 23(5):213-7. PubMed ID: 12227254
[TBL] [Abstract][Full Text] [Related]
30. Renal amyloidosis in a patient with X-linked agammaglobulinemia (Bruton's disease) and bronchiectasis.
Gonzalo-Garijo MA; Sánchez-Vega S; Pérez-Calderón R; Pérez-Rangel I; Corrales-Vargas S; Fernández de Mera JJ; Robles R
J Clin Immunol; 2014 Jan; 34(1):119-22. PubMed ID: 24292696
[TBL] [Abstract][Full Text] [Related]
31. [Beneficial effect of salazosulfapyridine (SASP) in a patient with secondary renal amyloidosis].
Hidaka M; Ohsawa I; Endo M; Fujita T; Ohi H; Kanmatsuse K; Kusumi Y; Yamaguchi Y
Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):555-9. PubMed ID: 9805922
[TBL] [Abstract][Full Text] [Related]
32. [Secondary amyloidosis (AA) and renal disease].
Torregrosa E; Hernández-Jaras J; Calvo C; Ríus A; García-Pérez H; Maduell F; Vera JM
Nefrologia; 2003; 23(4):321-6. PubMed ID: 14558331
[TBL] [Abstract][Full Text] [Related]
33. De novo amyloidosis in a renal transplant patient.
Yılmaz S; Özçakar ZB; Bulum B; Kiremitçi S; Ensari A; Ekim M; Keven K; Yalçınkaya F
Pediatr Transplant; 2014 Dec; 18(8):E259-61. PubMed ID: 25174445
[TBL] [Abstract][Full Text] [Related]
34. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
35. AA amyloidosis: basic knowledge, unmet needs and future treatments.
Obici L; Merlini G
Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707
[TBL] [Abstract][Full Text] [Related]
36. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis.
Westermark P; Sletten K; Eriksson M
Lab Invest; 1979 Nov; 41(5):427-31. PubMed ID: 502474
[TBL] [Abstract][Full Text] [Related]
37. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective.
Nobre CA; Callado MR; Rodrigues CE; de Menezes DB; Vieira WP
Rev Bras Reumatol; 2010; 50(2):205-10. PubMed ID: 21125155
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
[TBL] [Abstract][Full Text] [Related]
39. Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy.
Mpofu S; Teh LS; Smith PJ; Moots RJ; Hawkins PN
Rheumatology (Oxford); 2003 Feb; 42(2):362-6. PubMed ID: 12595637
[TBL] [Abstract][Full Text] [Related]
40. Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience.
Erdogmus S; Kendi Celebi Z; Akturk S; Kumru G; Duman N; Ates K; Erturk S; Nergizoglu G; Kutlay S; Sengul S; Keven K
Amyloid; 2018 Jun; 25(2):115-119. PubMed ID: 29775082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
